Department of Prosthetic Dentistry, Center for Dental Medicine, Medical Center - University of Freiburg, Faculty of Medicine - University of Freiburg, Freiburg, Germany.
Department of Oral and Maxillofacial Surgery, Berlin Institute of Health, Corporate Member of Freie Universität Berlin, Charité - Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
Clin Oral Implants Res. 2021 Apr;32(4):470-486. doi: 10.1111/clr.13716. Epub 2021 Feb 7.
To assess clinical and patient-reported outcomes of implant-prosthetic rehabilitations in patients with a history of head-neck cancer (HNC), treated with tumor resection without (TR) or with adjuvant radiotherapy (TR/RT). A healthy cohort rehabilitated with the same reconstructive protocols served as control group (C).
A total of 28 women and 29 men were considered in the present retrospective study. Participants received 322 implants, finally supporting 79 prosthetic reconstructions. Primary outcome was the assessment of implant and prosthetic survival rates. Furthermore peri-implant soft tissue parameters (attached peri-implant mucosa, AM; modified bleeding and plaque indices, mBI/mPI; probing depth, PD) and prosthetic technical complications were documented. Patient-reported outcome measures (PROMs) by means of visual analog scales (VAS) and the Oral Health Impact Profile German 14 form (OHIP G14) were collected. For statistical purposes Chi-square and Mann-Whitney-U-Test were adapted.
After a mean follow-up of 81.2 ± 50.3 months, implant survival rate was 98.1% (HNC-TR), 98.2% (HNC-TR/RT) and 100.0% (C), respectively (four implants failed in the HNC groups). HNC-TR/RT showed significant higher mPI and mBI compared to C. Within HNC-TR/RT, vestibuloplasty significantly reduced mBI and PD values. No failures occurred at the prosthetic level. Overall, higher VAS scores were reported for bar- compared with Locator-retained prostheses. Furthermore, increased OHIP G14 values resulted for HNC-TR/RT.
High survival rates on implant and prosthetic level were observed. The use of soft tissue grafts resulted in stabilization of the peri-implant mucosa in irradiated patients. In terms of retention and chewing ability, participants preferred bars over Locator attachments.
评估头颈部癌症(HNC)病史患者接受肿瘤切除术(TR)或辅助放疗(TR/RT)后行种植体-修复体重建的临床和患者报告结局。采用相同重建方案修复的健康队列作为对照组(C)。
本回顾性研究共纳入 28 名女性和 29 名男性。参与者共植入 322 枚种植体,最终支持 79 个修复体。主要结局为评估种植体和修复体的存活率。此外,记录了种植体周围软组织参数(附着黏膜,AM;改良出血和菌斑指数,mBI/mPI;探诊深度,PD)和修复体技术并发症。通过视觉模拟量表(VAS)和德国口腔健康影响简表 14 项(OHIP G14)收集患者报告结局(PROM)。统计分析采用卡方检验和曼-惠特尼 U 检验。
平均随访 81.2±50.3 个月后,种植体存活率分别为 98.1%(HNC-TR)、98.2%(HNC-TR/RT)和 100.0%(C)(HNC 组有 4 枚种植体失败)。HNC-TR/RT 的 mPI 和 mBI 显著高于 C。在 HNC-TR/RT 中,前庭成形术显著降低了 mBI 和 PD 值。修复体水平未发生失败。总体而言,杆状修复体的 VAS 评分高于Locator 附着修复体。此外,HNC-TR/RT 的 OHIP G14 值增加。
观察到种植体和修复体的高存活率。在接受放疗的患者中,使用软组织移植物可稳定种植体周围黏膜。在保留和咀嚼能力方面,参与者更喜欢杆状修复体而不是Locator 附着体。